Loading clinical trials...
Loading clinical trials...
A Phase I/II Study to Determine the Safety and Efficacy of a Combination of Green Tea and Quercetin With Docetaxel in Castration-resistant Prostate Cancer Patients
Conditions
Interventions
green tea and quercetin + docetaxel
Placebo + docetaxel
Locations
1
United States
Charles R. Drew University of Medicine and Science
Los Angeles, California, United States
Start Date
October 1, 2026
Primary Completion Date
April 1, 2028
Completion Date
February 1, 2029
Last Updated
April 15, 2026
NCT06004661
NCT03972657
NCT06134232
NCT06241846
NCT06344715
NCT04015622
Lead Sponsor
Charles Drew University of Medicine and Science
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions